Marian L Neuhouser

Dr. Marian L Neuhouser


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in JAMA Oncology
Verified
Journal Article
Open access
PDF file
MNMarian L Neuhouser
Marian L Neuhouser
AAAaron K. Aragaki
Aaron K. Aragaki
RPRoss L. Prentice
Ross L. Prentice
JMJoAnn E. Manson
JoAnn E. Manson
RCRowan Chlebowski
Rowan Chlebowski
GAGarnet L. Anderson
Garnet L. Anderson
Obesity is a major public health problem in the United States. Recent data demonstrate that the age-adjusted obesity (body mass index [BMI], calculated as weight in kilograms divided by height in meters squared, ≥30.0) prevalence is 34.9% among all adults 20 years or older while that for overweight plus obesity (BMI ≥ 25.0) is 68.5%.1 Obesity has been associated with breast cancer risk in observational studies,2,3 systematic reviews, and meta-analyses.3-5 More recently, the 2012 Annual Report to the Nation on Cancer6 concluded that overweight and obese women have a relative risk for postmenopausal breast cancer of 1.13 and 1.25, respectively, vs women of normal weight.

1 October 2019 in Nutrition Research
Verified
Journal Article
Closed access
MNMarian L Neuhouser
Marian L Neuhouser

30 August 2022 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
BLBruce Y Lee
Bruce Y Lee
JOJosé M Ordovás
José M Ordovás
EPElizabeth Parks
Elizabeth Parks
CACheryl A M Anderson
Cheryl A M Anderson
ABAlbert-László Barabási
Albert-László Barabási
MMMarie F Martinez
Marie F Martinez
Precision nutrition is an emerging concept that aims to develop nutrition recommendations tailored to different people's circumstances and biological characteristics. Responses to dietary change and the resulting health outcomes from consuming different diets may vary significantly between people based on interactions between their genetic backgrounds, physiology, microbiome, underlying health status, behaviors, social influences, and environmental exposures. On 11–12 January 2021, the National Institutes of Health convened a workshop entitled “Precision Nutrition: Research Gaps and Opportunities” to bring together experts to discuss the issues involved in better understanding and addressing precision nutrition. The workshop proceeded in 3 parts: part I covered many aspects of genetics and physiology that mediate the links between nutrient intake and health conditions such as cardiovascular disease, Alzheimer disease, and cancer; part II reviewed potential contributors to interindividual variability in dietary exposures and responses such as baseline nutritional status, circadian rhythm/sleep, environmental exposures, sensory properties of food, stress, inflammation, and the social determinants of health; part III presented the need for systems approaches, with new methods and technologies that can facilitate the study and implementation of precision nutrition, and workforce development needed to create a new generation of researchers. The workshop concluded that much research will be needed before more precise nutrition recommendations can be achieved. This includes better understanding and accounting for variables such as age, sex, ethnicity, medical history, genetics, and social and environmental factors. The advent of new methods and technologies and the availability of considerably more data bring tremendous opportunity. However, the field must proceed with appropriate levels of caution and make sure the factors listed above are all considered, and systems approaches and methods are incorporated. It will be important to develop and train an expanded workforce with the goal of reducing health disparities and improving precision nutritional advice for all Americans.

1 July 2009 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
GKGeoffrey C. Kabat
Geoffrey C. Kabat
MKMimi Kim
Mimi Kim
RCRowan T. Chlebowski
Rowan T. Chlebowski
JKJanu Khandekar
Janu Khandekar
MKMarcia G. Ko
Marcia G. Ko
TRThomas Rohan
Thomas Rohan
The metabolic syndrome, characterized by abdominal obesity, high blood glucose levels, impaired glucose tolerance, dyslipidemia, and hypertension, is associated with increased risk of type 2 diabetes and coronary heart disease. Several studies have examined the association of the individual components of the metabolic syndrome with breast cancer; to date, however, no study has assessed the metabolic syndrome per se in relation to breast cancer risk. Furthermore, previous studies have relied only on baseline assessment of components of the syndrome. Therefore, we assessed the association of the metabolic syndrome with the risk of postmenopausal breast cancer among women in the 6% sample of subjects in the Women's Health Initiative clinical trial and the 1% sample of women in the observational study who had repeated measurements of the components of the syndrome during follow-up. We used Cox proportional hazards models to estimate hazard ratios and 95% confidence intervals for the association of breast cancer risk with the presence of the metabolic syndrome, as well as its components, at baseline and in time-dependent analyses. After exclusion of women with diabetes, among 4,888 women with baseline measurements, 165 incident cases of breast cancer were ascertained over a median of 8 years of follow-up. The presence of the metabolic syndrome at baseline was not associated with altered risk. Of the individual components measured at baseline, diastolic blood pressure showed a borderline positive association with breast cancer. In time-dependent covariate analyses, however, certain scenarios indicated a positive association between the metabolic syndrome and breast cancer, due primarily to positive associations with serum glucose, serum triglycerides, and diastolic blood pressure. (Cancer Epidemiol Biomarkers Prev 2009;18(7):2046–53)